{"id":162736,"date":"2023-09-28T16:57:32","date_gmt":"2023-09-28T14:57:32","guid":{"rendered":"https:\/\/www.bordeaux-neurocampus.fr\/vih-et-hepatite-c-chez-les-personnes-qui-consomment-des-substances-par-injection-les-salles-de-consommation-limitent-les-pratiques-a-risques\/"},"modified":"2025-07-25T17:43:37","modified_gmt":"2025-07-25T15:43:37","slug":"vih-et-hepatite-c-chez-les-personnes-qui-consomment-des-substances-par-injection-les-salles-de-consommation-limitent-les-pratiques-a-risques","status":"publish","type":"post","link":"https:\/\/www.bordeaux-neurocampus.fr\/en\/vih-et-hepatite-c-chez-les-personnes-qui-consomment-des-substances-par-injection-les-salles-de-consommation-limitent-les-pratiques-a-risques\/","title":{"rendered":"VIH et h\u00e9patite C chez les personnes qui consomment des substances par injection : les salles de consommation limitent les pratiques \u00e0 risques"},"content":{"rendered":"<p>Parmi les auteur(e)s : Charlotte Kervran et Marc Auriacombe (Sanpsy)<\/p>\n<p><a href=\"https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2023\/09\/actu280923-creditadobestock-360x240.jpg\" rel=\"lightbox[162736]\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-162730\" src=\"https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2023\/09\/actu280923-creditadobestock-360x240.jpg\" alt=\"\" width=\"282\" height=\"188\" srcset=\"https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2023\/09\/actu280923-creditadobestock-360x240.jpg 360w, https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2023\/09\/actu280923-creditadobestock-136x91.jpg 136w, https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2023\/09\/actu280923-creditadobestock-640x426.jpg 640w, https:\/\/www.bordeaux-neurocampus.fr\/wp-content\/uploads\/2023\/09\/actu280923-creditadobestock.jpg 720w\" sizes=\"auto, (max-width: 282px) 100vw, 282px\" \/><\/a>La politique fran\u00e7aise de r\u00e9duction des risques de transmission des virus du VIH et de l\u2019h\u00e9patite C chez les personnes qui consomment des substances par injection inclue notamment l\u2019acc\u00e8s aux seringues st\u00e9riles et \u00e0 des salles de consommation \u00e0 moindre risque (SCMR). L\u2019\u00e9valuation de l\u2019efficacit\u00e9 des premi\u00e8res SCMR d\u00e9ploy\u00e9es en France en 2016 a \u00e9t\u00e9 confi\u00e9e \u00e0 l\u2019Inserm par la Mission interminist\u00e9rielle de lutte contre les conduites addictives.<\/p>\n<p>Dans ce cadre, une \u00e9quipe de chercheuses et de chercheurs de l\u2019Inserm, du CNRS, de l\u2019EHESS, de l\u2019Universit\u00e9 de Strasbourg, d\u2019Aix-Marseille Universit\u00e9 et de l\u2019Universit\u00e9 de Bordeaux, gr\u00e2ce \u00e0 des entretiens avec les usagers de drogues participant \u00e0 la cohorte Cosinus, a \u00e9valu\u00e9 l\u2019efficacit\u00e9 des SCMR sur la r\u00e9duction des pratiques \u00e0 risques \u2013 et en particulier du partage de mat\u00e9riel d\u2019injection.<\/p>\n<p>Leurs r\u00e9sultats montrent une diminution de 90 % du risque de partage de mat\u00e9riel entre les personnes ayant acc\u00e8s aux salles de consommation et celles ayant acc\u00e8s \u00e0 d\u2019autres types de structures de r\u00e9duction des risques. Ces travaux parus dans Addiction confirment l\u2019int\u00e9r\u00eat des SCMR dans la lutte contre les transmissions infectieuses et invitent \u00e0 renforcer le dispositif existant.<\/p>\n<h3>R\u00e9f\u00e9rence<\/h3>\n<p><strong>Drug Consumption Rooms are effective to reduce at-risk practices associated to HIV\/HCV infections among People who inject drugs. Results from the COSINUS cohort study<\/strong><\/p>\n<p>Lalanne Laurence<sup>1,2<\/sup><sup>\u2020<\/sup>, Roux Perrine<sup>,3<\/sup><sup>\u2020<\/sup>, Donadille C\u00e9cile<sup>3<\/sup>, Briand Madrid Laelia<sup>3<\/sup>, C\u00e9lerier Isabelle<sup>4<\/sup>, Chauvin Carole<sup>5<\/sup>, Hamelin Naomi<sup>1<\/sup>, <strong>Kervran Charlotte<\/strong><sup>6,7,8<\/sup>, Maradan Gwena\u00eblle<sup>4<\/sup>, <strong>Auriacombe Marc<\/strong><sup>6,7,8,9<\/sup><sup>\u2020<\/sup>, Jauffret-Roustide Marie<sup>5,10,11*<\/sup><sup>\u2020<\/sup> and the COSINUS study group<\/p>\n<p><sup>1 <\/sup>Inserm 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), 67000 Strasbourg, France<br \/>\n<sup>2<\/sup> Department of Psychiatry and Addictology, University Hospital of Strasbourg, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), 67000 Strasbourg, France<br \/>\n<sup>3 <\/sup>Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques &amp; Sociales de la Sant\u00e9 &amp; Traitement de l&#8217;Information M\u00e9dicale, ISSPAM, Marseille, France<br \/>\n<sup>4<\/sup> ORS PACA, Observatoire r\u00e9gional de la sant\u00e9 Provence-Alpes-C\u00f4te d\u2019Azur, Marseille, France<br \/>\n<sup>5 <\/sup>Centre d\u2019\u00e9tude des mouvements sociaux (Inserm U1276\/UMR CNRS 8044\/EHESS\/Paris), Paris, France<br \/>\n<sup>6 <\/sup>CH Charles Perrens and CHU de Bordeaux, P\u00f4le inter-\u00e9tablissement Addictologie, Bordeaux, France<br \/>\n<sup>7 <\/sup>Addiction Team, SANPSY, CNRS UMR 6033, Bordeaux, France<br \/>\n<sup>8 <\/sup>Department of psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA<br \/>\n<sup>9<\/sup> Universit\u00e9 de Bordeaux, France<br \/>\n<sup>10<\/sup> British Columbia Center on Substance Use (BCCSU), Vancouver, Canada<br \/>\n<sup>11 <\/sup>Baldy Center on Law and Social Policy, Buffalo University, New York, USA<\/p>\n<p><strong><em>Addiction : <a href=\"https:\/\/doi.org\/10.1111\/add.16320\">https:\/\/doi.org\/10.1111\/add.16320<\/a><\/em><\/strong><\/p>\n<h3>Lire le communiqu\u00e9 de presse<\/h3>\n<p><a href=\"https:\/\/presse.inserm.fr\/vih-et-hepatite-c-chez-les-personnes-qui-consomment-des-substances-par-injection-les-salles-de-consommation-limitent-les-pratiques-a-risques\/67517\/\">https:\/\/presse.inserm.fr\/<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Communiqu\u00e9 de presse. Travaux de l&#8217;unit\u00e9 Sanpsy<\/p>\n","protected":false},"author":108,"featured_media":162731,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71,777],"tags":[],"class_list":["post-162736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-highlight-en","category-sanpsy-en"],"_links":{"self":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts\/162736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/users\/108"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/comments?post=162736"}],"version-history":[{"count":1,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts\/162736\/revisions"}],"predecessor-version":[{"id":162738,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/posts\/162736\/revisions\/162738"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/media\/162731"}],"wp:attachment":[{"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/media?parent=162736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/categories?post=162736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bordeaux-neurocampus.fr\/en\/wp-json\/wp\/v2\/tags?post=162736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}